Vertebroplasty: Expectation or Evidence-Based Interventional Radiology?

References

1. 1.↵
   2. Chandra RV,
   3. Maingard J,
   4. Asadi H, et al

   . Vertebroplasty and kyphoplasty for osteoporotic vertebral fractures: what are the latest data? AJNR Am J Neuroradiol 2018;39:798–806 doi:10.3174/ajnr.A5458 pmid:29170272

   Abstract/FREE Full Text
2. 2.↵
   2. Galibert P,
   3. Deramond H,
   4. Rosat P, et al

   . Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty [in French]. Neurochirurgie 1987;33:166–68 pmid:3600949

   PubMedWeb of Science
3. 3.↵
   2. Clark W,
   3. Bird P,
   4. Gonski P, et al

   . Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo controlled trial. Lancet 2016;388:1408–16 doi:10.1016/S0140-6736(16)31341-1 pmid:27544377

   CrossRefPubMed
4. 4.↵
   2. Firanescu CE,
   3. de Vries J,
   4. Lodder P, et al

   . Vertebroplasty versus sham procedure for painful acute osteoporotic vertebral compression fractures (VERTOS IV): randomised sham controlled clinical trial. BMJ 2018;361:k1551 doi:10.1136/bmj.k1551 pmid:29743284

   Abstract/FREE Full Text
5. 5.↵
   2. Wheatley K,
   3. Ives N,
   4. Gray R, et al

   ; ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med 2009;361:1953–62 doi:10.1056/NEJMoa0905368 pmid:19907042

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Greene HL,
   3. Roden DM,
   4. Katz RJ, et al

   . The Cardiac Arrhythmia Suppression Trial: first CAST…then CAST-II. J Am Coll Cardiol 1992;19:894–98 doi:10.1016/0735-1097(92)90267-Q pmid:1552108

   FREE Full Text
7. 7.↵
   2. Kim C,
   3. Prasad V

   . Strength of validation for surrogate end points used in the US Food and Drug Administration's approval of oncology drugs. Mayo Clin Proc 2016 May 10. [Epub ahead of print] doi:10.1016/j.mayocp.2016.02.012 pmid:27236424

   CrossRefPubMed
8. 8.↵
   2. Braillon A

   . Sciensationalism. Am J Med 2011;124:e13 doi:10.1016/j.amjmed.2010.07.024 pmid:20887967

   CrossRefPubMed
9. 9.↵
   2. Braillon A

   . Direct-acting antiviral drugs and hepatitis C virus: a therapeutic revolution? Cancer 2015;121:4268–69 doi:10.1002/cncr.29648 pmid:26287922

   CrossRefPubMed